Creative Biolabs Launches Diverse Services for Engineered Therapeutic Strain Design

October 24 13:48 2023
Creative Biolabs, a US-based biotech company dedicated to live biotherapeutic research for years, has launched diverse services and advanced technologies for the design of engineered therapeutic strains.

New York, USA – October 24, 2023 – Recent advances in the engineering of therapeutic strains are paving the way for innovative solutions in treating various diseases. The potential of these engineered bacteria has been dramatically accelerated by advancements in synthetic biology and microbial genomics. Based on extensive experience in the design of engineered therapeutic strains, Creative Biolabs is excited to announce a full range of well-rounded services regarding probiotic strains to meet the demands of global researchers in this field.

Therapeutic strains are genetically modified bacteria specifically designed for different applications in medicine. Creative Biolabs’ experts are harnessing their in-depth knowledge and pioneering techniques to offer recombinant Lactobacillus expression strain construction services. Using their expertise, this company strives to create optimal expression strains that can elevate research advancements in therapeutic areas such as gastrointestinal diseases, allergies, and obesity.

Engineered Escherichia coli Nissle 1917 (EcN) is a beneficial strain currently under investigation for its potential application as a probiotic treatment option for multiple conditions,” commented an expert at Creative Biolabs. “We can provide reliable Genetic Modified Services for EcN to advance the engineering of EcN-based therapeutics research.”

In addition, Creative Biolabs grasps the technology of synchronized lysis circuits. This technology significantly improves the delivery and efficacy of therapeutics. It involves designing bacteria that could explode and deliver the drugs simultaneously, thus providing a higher therapeutic impact. Creative Biolabs intends to push this frontier by designing and optimizing genetically modified strains to enhance the potential of synchronized lysis technology in therapeutic drug delivery.

According to the director at Creative Biolabs, “To further enhance efficacy in the implementation of these new services, our company is armed with cutting-edge facilities and an expert team of scientists trained in various areas of strain construction, recombinant protein, and DNA technology.”

To learn more information about services regarding the design of engineered therapeutic strains, please visit https://live-biotherapeutic.creative-biolabs.com.

About Creative Biolabs

Creative Biolabs is a leading life sciences company providing custom services for the development of microbial therapeutics. With state-of-the-art tools and outstanding expertise in synthetic biology and microbiology, this company offers a wide array of solutions for bacterial engineering, strain selection, functional validation, and design. Emphasizing quality, innovation, and customer satisfaction, Creative Biolabs strives to foster innovation in the field of microbiota therapeutics to address challenges.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://live-biotherapeutic.creative-biolabs.com